Back
Neogen Corp. 10K Form
Buy
56
NEOG
Neogen Corp.
Last Price:
$7.20
Seasonality Move:
4.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-09 | 10Q | NEOG/Neogen Corp. Quarterly |
| 2024-01-09 | 10Q | NEOG/Neogen Corp. Quarterly |
| 2023-10-10 | 10Q | NEOG/Neogen Corp. Quarterly |
| 2023-08-15 | 10K | NEOG/Neogen Corp. Annual |
| 2023-04-04 | 10Q | NEOG/Neogen Corp. Quarterly |
| 2023-01-09 | 10Q | NEOG/Neogen Corp. Quarterly |
Receive NEOG News And Ratings
See the #1 stock for the next 7 days that we like better than NEOG
NEOG Financial Statistics
Sales & Book Value
| Annual Sales: | $894.7M |
|---|---|
| Cash Flow: | $-13.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $9.75 |
| Price / Book: | 0.74 |
Profitability
| EPS (TTM): | -4.80840 |
|---|---|
| Net Income (TTM): | $-1B |
| Gross Margin: | $421.4M |
| Return on Equity: | -41.21% |
| Return on Assets: | -26.81% |
Neogen Corp. Earnings Forecast
Key Neogen Corp. Financial Ratios
-
The Gross Profit Margin over the past 38 years for NEOG is 47.10%.
-
The Selling, General & Administrative Expenses for NEOG have been equal to 44.93% of Gross Profit Margin.
-
The Research & Development expenses have been 2.36% of Revenue.
-
The Net Earning history of NEOG is -122.06% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 26 years.
Neogen Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NEOG |
| CUSIP: | 640491 |
| Website: | neogen.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 3.58 |
| Quick Ratio: | 1.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 20 |
NEOG Technical Analysis vs Fundamental Analysis
Buy
56
Neogen Corp. (NEOG)
is a Buy
Is Neogen Corp. a Buy or a Sell?
-
Neogen Corp. stock is rated a BuyThe current Neogen Corp. [NEOG] share price is $7.20. The Score for NEOG is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.